JPWO2020000092A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020000092A5 JPWO2020000092A5 JP2021522114A JP2021522114A JPWO2020000092A5 JP WO2020000092 A5 JPWO2020000092 A5 JP WO2020000092A5 JP 2021522114 A JP2021522114 A JP 2021522114A JP 2021522114 A JP2021522114 A JP 2021522114A JP WO2020000092 A5 JPWO2020000092 A5 JP WO2020000092A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- amount
- composition according
- per
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 22
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 claims 10
- 239000005537 C09CA07 - Telmisartan Substances 0.000 claims 5
- 229960005187 telmisartan Drugs 0.000 claims 5
- 238000000034 method Methods 0.000 claims 3
- 208000017169 kidney disease Diseases 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 201000002793 renal fibrosis Diseases 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862690738P | 2018-06-27 | 2018-06-27 | |
| US62/690,738 | 2018-06-27 | ||
| US201962809330P | 2019-02-22 | 2019-02-22 | |
| US62/809,330 | 2019-02-22 | ||
| PCT/CA2019/050881 WO2020000092A1 (en) | 2018-06-27 | 2019-06-25 | The use of actarit in the prophylaxis or treatment of renal fibrosis or kidney disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021529829A JP2021529829A (ja) | 2021-11-04 |
| JPWO2020000092A5 true JPWO2020000092A5 (enrdf_load_stackoverflow) | 2022-07-06 |
| JP7304944B2 JP7304944B2 (ja) | 2023-07-07 |
Family
ID=68985352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522114A Active JP7304944B2 (ja) | 2018-06-27 | 2019-06-25 | 腎線維症又は腎疾患の予防又は治療におけるアクタリットの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12280026B2 (enrdf_load_stackoverflow) |
| EP (2) | EP3813817A4 (enrdf_load_stackoverflow) |
| JP (1) | JP7304944B2 (enrdf_load_stackoverflow) |
| CN (1) | CN112423742B (enrdf_load_stackoverflow) |
| CA (1) | CA3105127A1 (enrdf_load_stackoverflow) |
| WO (1) | WO2020000092A1 (enrdf_load_stackoverflow) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12290510B2 (en) * | 2019-02-07 | 2025-05-06 | Riesner Verwaltungs Gmbh | Polyvalent derivatives of emoxypine |
| WO2020191502A1 (en) * | 2019-03-27 | 2020-10-01 | Algernon Pharmaceuticals Inc. | Use of emoxypine and derivatives thereof for treating kidney disorders and inflammatory bowel disease |
| WO2020191501A1 (en) * | 2019-03-27 | 2020-10-01 | Algernon Pharmaceuticals Inc. | Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders |
| WO2020191503A1 (en) * | 2019-03-27 | 2020-10-01 | Algernon Pharmaceuticals Inc. | Methods and uses of bromantane and derivatives thereof for treating lung disease, fatty liver disease, and kidney disorders |
| CN113368106B (zh) * | 2020-02-25 | 2023-09-29 | 渐宽(苏州)生物科技有限公司 | 艾托莫德用于防治特发性肺纤维化的药物中的用途 |
| IT202100014177A1 (it) * | 2021-05-31 | 2022-12-01 | Sunnutrapharma S R L | Utilizzo della istradefillina per ridurre la fibrosi d’organo |
| WO2025040956A2 (en) * | 2023-08-09 | 2025-02-27 | Rautiola Davin | Drug to treat stimulant addiction |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU1601978C (ru) * | 1988-12-29 | 1995-10-27 | Научно-исследовательский институт фармакологии РАМН | Способ получения n-(4-бромфенил)-n-(2-адамантил)амина |
| RU2109727C1 (ru) * | 1994-06-10 | 1998-04-27 | Научно-исследовательский институт фармакологии РАМН | Способ получения адамантан-2-она |
| ATE381538T1 (de) * | 2001-04-16 | 2008-01-15 | Taiho Pharmaceutical Co Ltd | Suplatast tosilat kristalle |
| JP2005089345A (ja) * | 2003-09-16 | 2005-04-07 | Tendou Seiyaku Kk | 虫刺され治療薬 |
| US7838552B2 (en) * | 2004-06-04 | 2010-11-23 | Forest Laboratories Holdings Limited | Compositions comprising nebivolol |
| JP4794148B2 (ja) * | 2004-09-10 | 2011-10-19 | 大鵬薬品工業株式会社 | ネフローゼ症候群治療剤 |
| US20070014734A1 (en) * | 2005-01-31 | 2007-01-18 | O'donnell John P | Glucuronidated nebivolol metabolites |
| EP1942909A4 (en) * | 2005-10-04 | 2010-01-06 | Nitromed Inc | METHODS OF TREATING RESPIRATORY DISORDERS |
| ATE526014T1 (de) * | 2006-12-26 | 2011-10-15 | Taiho Pharmaceutical Co Ltd | Therapeutisches mittel gegen diabetische neuropathie |
| RU2619105C2 (ru) * | 2011-09-29 | 2017-05-12 | Оно Фармасьютикал Ко., Лтд. | Фенильное производное |
| MX2016003979A (es) * | 2013-10-03 | 2016-06-15 | Millennium Pharm Inc | Metodo para profilaxis o tratamiento de lupus eritematoso sistemico y/o nefritis lupica. |
| WO2017032384A1 (en) * | 2015-08-25 | 2017-03-02 | Conrig Pharma Aps | Compound and use in the treatment of cough |
| ES2862799T3 (es) * | 2015-12-23 | 2021-10-07 | Conrig Pharma Aps | Tosilato de suplatast para tratar la tos asociada con neumopatía intersticial |
| ES3037948T3 (en) | 2018-04-20 | 2025-10-08 | Tetra Laval Holdings & Finance | A sealed package containing a pourable food product and a sheet packaging material for producing a sealed package containing a pourable food product |
-
2019
- 2019-06-25 CA CA3105127A patent/CA3105127A1/en active Pending
- 2019-06-25 CN CN201980043698.6A patent/CN112423742B/zh active Active
- 2019-06-25 EP EP19827430.0A patent/EP3813817A4/en not_active Withdrawn
- 2019-06-25 WO PCT/CA2019/050881 patent/WO2020000092A1/en not_active Ceased
- 2019-06-25 EP EP22165228.2A patent/EP4046633A1/en active Pending
- 2019-06-25 JP JP2021522114A patent/JP7304944B2/ja active Active
- 2019-06-25 US US17/255,364 patent/US12280026B2/en active Active